Your browser doesn't support javascript.
loading
[Preliminary study of the fourth-generation CAR-T cells targeting CS1 in the treatment of refractory and recurrent multiple myeloma].
Feng, D D; Chen, X H; Guo, J J; Wang, K K; Zhang, X M; Gao, J M.
Afiliación
  • Feng DD; School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, China.
  • Chen XH; School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, China.
  • Guo JJ; School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, China.
  • Wang KK; School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, China.
  • Zhang XM; School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, China.
  • Gao JM; School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, China.
Zhonghua Zhong Liu Za Zhi ; 43(6): 657-665, 2021 Jun 23.
Article en Zh | MEDLINE | ID: mdl-34289557

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Animals Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Animals Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Año: 2021 Tipo del documento: Article País de afiliación: China